Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A new institute for nanoscience research is to open in Oxford thanks to a $10 million gift from The Kavli Foundation.

Biochemistry Building Completion

The new Kavli Institute for NanoScience Discovery (Kavli INSD) at Oxford will be a unique combination of structural biology with world-leading biochemistry, pathology, chemistry, physics, physiology and engineering. Based in a new building at the centre of Oxford’s Science Area site, it will house more than 40 faculty and 400 students, postdocs and research staff.

It will be the 20th Kavli Institute globally and The Kavli Foundation’s fifth institute in nanoscience when it opens its doors in January 2021.

Professor Gavin Screaton, Head of Oxford University’s Medical Sciences Division, said: “Oxford has a rich tradition as a research-driven university and the addition of a Kavli Institute will enhance that collaborative nature that helps us to deliver exceptional education, to carry out world-leading research, and to make significant contributions to society – locally, nationally and internationally.

'The multidisciplinary nature of nanoscience broadens the possibilities for discoveries, which can translate into innovations that can benefit economies and humanity worldwide, such as the development of the gene-editing technology CRISPR.'

The full story is available on the University of Oxford website

Similar stories

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.

Three NHSBT research units launch at University of Oxford

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.

Fourth COVID-19 vaccine dose provides stronger immunity boost than third dose, shows UK study

COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from a nationwide NIHR-supported study.

COVID-19’s high blood clot risk

A recent study of patient health records found that around 1 in 100 people with COVID-19 had a venal or arterial thrombosis, with rates higher still among males, and particularly for those hospitalised.